Prucalopride in Pediatric Subjects With Functional Constipation
Status:
Completed
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy of prucalopride compared to placebo for the treatment of functional
constipation in a paediatric population, aged ≥ 6 months to < 18 years. A 16-week open-label
comparator (PEG) controlled part will follow, to document safety and tolerability up to 24
weeks.